ROYAL BANK OF CANADA - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$17,000
-41.4%
3,760
-54.9%
0.00%
Q4 2018$29,000
-90.5%
8,330
-72.5%
0.00%
Q3 2018$306,000
+39.1%
30,335
-0.2%
0.00%
Q2 2018$220,000
+10.6%
30,390
-7.6%
0.00%
Q1 2018$199,000
-40.6%
32,874
-5.6%
0.00%
Q4 2017$335,000
+29.8%
34,829
+19.7%
0.00%
Q3 2017$258,000
+49.1%
29,102
+112.5%
0.00%
Q2 2017$173,000
+140.3%
13,695
+100.9%
0.00%
Q1 2017$72,000
+213.0%
6,818
+178.5%
0.00%
Q4 2016$23,000
-32.4%
2,448
-16.9%
0.00%
Q3 2016$34,000
+17.2%
2,945
+29.0%
0.00%
Q2 2016$29,000
-23.7%
2,283
-4.3%
0.00%
Q1 2016$38,000
+81.0%
2,386
+219.4%
0.00%
Q4 2015$21,000
-62.5%
747
-61.9%
0.00%
Q3 2015$56,000
-85.5%
1,960
-81.8%
0.00%
Q2 2015$387,000
+6350.0%
10,788
+11255.8%
0.00%
Q1 2015$6,000
-90.0%
95
-93.3%
0.00%
Q4 2014$60,000
-23.1%
1,425
-28.8%
0.00%
Q3 2014$78,000
+56.0%
2,000
+25.0%
0.00%
Q2 2014$50,000
-29.6%
1,600
-7.2%
0.00%
Q1 2014$71,000
+273.7%
1,725
+245.0%
0.00%
Q4 2013$19,000
-94.3%
500
-94.7%
0.00%
Q3 2013$332,0009,4840.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2018
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders